PLoS ONE (Jan 2015)

The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD.

  • Eino Solje,
  • Heidi Aaltokallio,
  • Heli Koivumaa-Honkanen,
  • Noora M Suhonen,
  • Virpi Moilanen,
  • Anna Kiviharju,
  • Bryan Traynor,
  • Pentti J Tienari,
  • Päivi Hartikainen,
  • Anne M Remes

DOI
https://doi.org/10.1371/journal.pone.0131817
Journal volume & issue
Vol. 10, no. 7
p. e0131817

Abstract

Read online

The C9ORF72 expansion is one of the most common genetic etiologies observed with behavioural variant frontotemporal dementia (bvFTD). Revised diagnostic criteria for bvFTD (FTDC) were recently introduced but only a few studies have evaluated the accuracy of these criteria.The objective of the study was to evaluate the applicability of the FTDC criteria and assess the psychiatric history of these patients.The study examined 36 patients carrying the C9ORF72 expansion and suffering from bvFTD (N = 32) or from bvFTD with motor neuron disease (bvFTD-MND, N = 4). Neuropsychological, neuropsychiatric, structural brain imaging and PET/SPECT data were evaluated.We found 0.75 sensitivity (SD 0.44, 95%CI 0.57-0.87) for possible bvFTD and 0.64 (SD 0.44, 95%CI 0.57-0.87) for probable bvFTD. The sensitivity was even higher in bvFTD patients without MND, i.e., 0.81 for possible bvFTD and 0.69 for probable bvFTD. PET/SPECT was normal in 17.6% of scanned patients with bvFTD. A history of psychiatric symptoms (psychotic and/or mood symptoms) was detected in 61% of cases.The FTDC possible and probable bvFTD criteria seem to identify the majority of the C9ORF72 expansion carriers with bvFTD, even though they exhibit only a limited number of behavioral criteria but a significant amount of psychiatric symptoms. The presence of a normal PET/SPECT does not exclude the possibility the C9ORF72 associated bvFTD.